Metagenomi Therapeutics (MGX) Cash from Operations (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Cash from Operations of 21175000.0 for Q1 2026, up 7.3% year-over-year from 19734764.78 in Q1 2025, and up 10.07% quarter-over-quarter from 23546000.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Cash from Operations (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Cash from Operations data on file, last reported at 21175000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 21175000.0, up 7.3% year-over-year; the trailing twelve-month figure through Mar 2026 was 87225000.0 (up 14.54% YoY), and the FY2025 annual result was 88892000.0, up 18.5% from the prior year.
- Cash from Operations advanced to 21175000.0 in Q1 2026 per MGX's latest filing, from 23546000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 20592000.0 in Q4 2023 and troughed at 29850000.0 in Q1 2024.
- A 4-year average of 23888384.62 and a median of 23546000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations plunged 42.18% in 2024, then grew 23.48% in 2025.
- A 4-year view of Cash from Operations shows it stood at 20592000.0 in 2023, then decreased by 27.6% to 26276000.0 in 2024, then gained by 10.39% to 23546000.0 in 2025, then rose by 10.07% to 21175000.0 in 2026.
- Business Quant data shows MGX's Cash from Operations at 21175000.0 in Q1 2026, 23546000.0 in Q4 2025, and 21253000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | -21.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.18 Mn |
| Mar 31, 2026 | -21.18 Mn |
| Dec 31, 2025 | -23.55 Mn |
| Dec 31, 2025 | -23.55 Mn |
| Sep 30, 2025 | -21.25 Mn |
| Sep 30, 2025 | -21.25 Mn |
| Jun 30, 2025 | -21.25 Mn |
| Jun 30, 2025 | -21.25 Mn |
| Mar 31, 2025 | -22.84 Mn |
| Mar 31, 2025 | -22.84 Mn |
| Dec 31, 2024 | -26.28 Mn |
| Dec 31, 2024 | -26.28 Mn |
| Sep 30, 2024 | -26.64 Mn |
| Sep 30, 2024 | -26.64 Mn |
| Jun 30, 2024 | -26.31 Mn |
| Jun 30, 2024 | -26.31 Mn |
| Mar 31, 2024 | -29.85 Mn |
| Mar 31, 2024 | -29.85 Mn |
| Dec 31, 2023 | -20.59 Mn |
| Dec 31, 2023 | -20.59 Mn |